Results 191 to 200 of about 199,607 (256)
Corporate ESG Greenwashing: Does Regulatory Proximity Matter?
ABSTRACT Environmental, social, and governance (ESG) greenwashing undermines sustainable development, yet the influence of regulatory proximity on oversight is understudied. By introducing the “distance decay effect” from geoeconomics into ESG misconduct research and using a sample of Chinese listed firms from 2009 to 2022, this study reveals a ...
Weiqi Zhao +4 more
wiley +1 more source
Supporting the creative industries through the AI turn: A comparative analysis of Scottish policy and the needs of Scotland's creative practitioners. [PDF]
Black SR +4 more
europepmc +1 more source
ABSTRACT Whether corporate carbon management can enhance productive efficiency is central to firms' long‐term competitiveness and determines whether carbon reduction efforts can be sustained beyond regulatory compliance. This study examines how corporate carbon risk and opportunity management affects firm productivity (measured by total factor ...
Nan Huang, Hanlu Fan, Ruoxin Zhu
wiley +1 more source
Stock Market Reactions to Climate Risk Events: A Systematic Literature Review and Research Agenda
ABSTRACT As global warming intensifies, climate risks' impact on firm value has become a critical concern for academia and investors. This systematic literature review analyzes 50 event studies in this research field, classifying them by climate risk type.
Mario Schuster, Rainer Lueg
wiley +1 more source
Beyond reproductive rights: implementing the Africentric reproductive justice framework in sexual and reproductive health and rights litigations in Africa. [PDF]
Mulumba M, Oga J, Muhumuza N.
europepmc +1 more source
ABSTRACT Despite growing public knowledge of false confession cases, research with students and community members continues to find that people assume confessions indicate guilt. The present research explored the implications of belief perseverance: the tendency to maintain a belief even when confronted with compelling contradictory evidence.
Taya D. Henry +2 more
wiley +1 more source
Global practices in AT provision: considerations for a national assistive technology policy for health in India. [PDF]
Srivastava RK +4 more
europepmc +1 more source
Abstract Artificial intelligence and automation are no longer just buzzwords in the biopharmaceutical industry. The manufacturing of a class of biologics, comprising monoclonal antibodies, cell therapies, and gene therapies, is far more complex than that of traditional small molecule drugs.
Shyam Panjwani, Hao Wei, John Mason
wiley +1 more source

